Haleon US Holdings LLC

Form 483 issued September 11, 2018 · East Durham, New York

Inspection
Aug 30 – Sep 11, 2018
Observations
2
Pages
4
FEI number
1314819

In short: On September 11, 2018, FDA issued a Form 483 with 2 observations to Haleon US Holdings LLC in East Durham, New York (FEI 1314819) after an inspection that ran Aug 30 – Sep 11, 2018. The investigator was Rajiv R. Srivastava. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.110 (sampling and testing of in-process materials and drug products).

At a glance

Production and quality system account for 2 of 2 observations.

Production1
Quality system1

Most cited: 21 CFR 211.110(a) (1×) · 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Control procedures are not established which validate the performance of those manufacturing processes that may be…

  2. 02

    The responsibilities and procedures applicable to the quality control unit are not in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Haleon US Holdings LLC?

FDA listed 2 observations on this Form 483, mostly about production and quality system. The most-cited regulation is 21 CFR 211.110 (sampling and testing of in-process materials and drug products). The opening words of each observation are shown on this page.

Who inspected Haleon US Holdings LLC?

Rajiv R. Srivastava is named on this Form 483, for the inspection of Aug 30 – Sep 11, 2018. Each investigator has a profile showing what they cite most.

When was Haleon US Holdings LLC inspected by FDA?

The inspection ran Aug 30 – Sep 11, 2018, and the Form 483 is dated September 11, 2018.

How do I get the full Form 483 for Haleon US Holdings LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free